Just stating some facts.
1. PAB renews a takeover provision at the AGM. I mean - how many companies have you seen with AGM resolutions with a takeover provision - very rare
2. The following month - Amgen (who are a notorious predator and acquired Onyx at $10.4b mainly for their MM drug which PAB is trialling with) takes a huge interest in PAB's SM6.
3. How is PAB issuing so much paper which exceeds the 15% + 10% allowable amount under ASX listing rule 7.1a. There require further shareholder approval for the rights issue. So an EGM will be have to be called to approve this retrospectively. The question is what else will be on that EGM's agenda. Perhaps approval of a bid?
I've never seen so many 'dots' in a a company before which can be so easily joined.
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 89862129 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 33482941 | 23 |
View Market Depth
| Last trade - 16.21pm 15/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable